Endocrine Society

Short version — look for board-certified specialists who use evidence-based testing, explain risks and alternatives, use FDA-approved products when appropriate, and follow you with labs and symptoms. Avoid clinics that sell “one-size-fits-all” pellets or prescribe from a checkbox visit without labs or ongoing follow-up. Concrete checklist (what to require) Provider credentials: board-certified (endocrinologist, gynecologist, urologist, or family physician with relevant board certification). Verify on ABMS (American Board of Medical Specialties). Specialty experience: menopause or hormone-management experience; preferably a North American Menopause Society (NAMS) Certified Menopause Practitioner (NCMP). Evidence-based testing: baseline and follow-up labs (serum tests for most systemic hormones). Be wary of clinics that rely only on saliva tests. Informed consent and risk discussion: documented discussion of benefits, risks (breast, clotting, CV, liver, acne, mood, fertility impacts), and alternatives. Individualized dosing plus scheduled follow-up and lab monitoring (not just a one-time Rx or implants placed with no follow-up). Pharmacy transparency: if they use compounded hormones, the pharmacy should be accredited (PCAB/ACHC) and willing to provide quality-control documentation. Prefer FDA‑approved formulations when available. Clear pricing and written plan for starting, adjusting, and stopping therapy. Questions to ask a prospective clinic Are you board-certified in (specialty)? Can I see your credentials? Do you follow evidence-based guidelines? Which guidelines do you use? What tests do you order before prescribing? How often will you monitor me? Do you use saliva tests, urine DUTCH, or serum blood tests — and why? Do you prescribe FDA‑approved hormone products first, or go straight to compounded bioidentical hormones? Which compounding pharmacy do you use and is it accredited? What are the expected benefits and the risks for my age/health profile? How long before we reassess? Red flags (avoid clinics that:) Prescribe hormones after a 10–15 minute visit or only an online questionnaire. Rely exclusively on saliva testing for systemic hormone replacement. Use “hormone pellet” implants as the only or default treatment without detailed evaluation and monitoring. Promise dramatic anti‑aging effects or “cure” claims. Sell the hormones directly with pressure to purchase on site. Provide no written consent or follow-up testing plan. Specific organizations and services to consider (and why) Mayo Clinic, Cleveland Clinic, Johns Hopkins — large academic centers; multidisciplinary, evidence-based care and easy ways to verify clinician credentials. Good if you want a conservative, guideline-driven approach. North American Menopause Society (NAMS) — use their “Find a Provider” tool to locate NAMS‑qualified clinicians (NCMP) who specialize in menopause care. NAMS also publishes position statements and guidance. Endocrine Society / American College of Obstetricians and Gynecologists (ACOG) — professional guidelines and patient resources that reflect current evidence. Ask clinics whether they follow these guidelines. Quest Diagnostics or LabCorp — commonly used, reliable labs for standard serum hormone testing. Precision Analytical (DUTCH test) — a well-known specialized urinary steroid metabolite test; it can be useful in specialized situations but should be interpreted by a clinician familiar with its limitations. Look for compounding pharmacies accredited by PCAB/ACHC (ask the clinic which pharmacy they use and verify). If an FDA‑approved product exists for your indication, prefer it (examples of FDA‑approved formulations include estradiol patches like Climara or Vivelle‑Dot, oral estradiol Estrace, and micronized progesterone Prometrium). Practical next steps Start with a local academic menopause or women’s health clinic or use NAMS to find an NCMP. Verify the clinician’s board certification (ABMS) and ask about their experience with BHRT. Ask for a copy of the clinic’s evaluation protocol (what labs, imaging, follow-up intervals). If a clinic recommends compounded hormones, ask which pharmacy and check its accreditation and testing procedures. Get everything in writing (treatment plan, monitoring schedule, stop criteria, costs). If you want, tell me your city or zip code and whether you’re looking for in‑person or telehealth care; I can suggest local clinics or vetted telemedicine services and help you prepare a short list of questions to bring to the appointment.

Mentioned in position 5 of 13

There is no single “best” BHRT method; the optimal choice depends on your priorities for stability vs. adjustability, convenience, and insurance coverage. Pellets are best for maximum convenience and steady hormone levels (no daily dosing, lasts 3–5 months), but they are not adjustable once inserted and are not FDA-approved (compounded by specialty pharmacies) [1][3][9]. Major societies like The Menopause Society and Endocrine Society do not recommend pellets as a preferred method due to safety concerns and lack of large randomized trials [6][9]. Patches (FDA-approved) are best for clinical reliability and safety, offering steady release (3–7 days) with dose flexibility and the ability to remove them immediately if side effects occur [1][5][9]. They are often covered by insurance and are the default recommendation for most women starting therapy [5]. Creams are best for fine-tuning dosing and ease of use, allowing daily adjustments based on labs, but they have more variable absorption than patches or pellets [1][3][9]. Comparison Summary Feature Pellets Patches (FDA-approved) Creams Duration 3–5 months [1][3] 3–7 days [1] Daily [3] Adjustability ❌ None once inserted [9] ✅ Yes (different strengths) [1][9] ✅ Yes (daily dose) [1][9] Stability ✅ Flattest curve (steady) [1][9] ✅ Steady state [1] ⚠️ Variable absorption [1][11] FDA Status ❌ Compounded (not approved) [6][9] ✅ FDA-approved [1][5] ❌ Compounded (not approved) [5] Insurance ⚠️ Often not covered [6] ✅ Usually covered [5] ⚠️ Often not covered [5] Procedure In-office implant (buttock) [1][6] Simple application [1] Simple application [3] Best For Convenience, no daily hassle [3] Safety, evidence, adjustability [9] Precision dosing [9] Who Offers Them? Pellets: Offered by specialized BHRT clinics and wellness centers (e.g., The Wellness Co. [1], APMUC using EvexiPEL [7], Naya Wellness [5], Salt Lake City Gyn [2]). Note: These are compounded products, not FDA-approved.* Patches: Offered by any licensed healthcare provider (gynecologists, primary care, endocrinologists) who can prescribe FDA-approved brands like Climara, Vivelle-Dot, Minivelle, or Combipatch [1]. These are widely available through standard pharmacies. Creams: Offered by BHRT-focused clinics and integrative doctors (e.g., The Wellness Co. [1], Infusion Health [3], Naya Wellness [5]). Like pellets, these are typically compounded (e.g., Bi-Est 50/50) and require a specialty pharmacy. Recommendation: If you prioritize safety and evidence, start with FDA-approved patches. If you prioritize convenience and hate daily dosing and accept the lack of FDA oversight, pellets are a popular alternative, but discuss the risks with your provider [6][9].

Mentioned in position 2 of 12

Short answer “Bioidentical” simply means the hormone molecule is chemically identical to the hormone your body makes (for example, estradiol or micronized progesterone). Some bioidentical products are FDA‑approved prescription drugs; others are custom‑made (“compounded”) by pharmacies and are not FDA‑tested. Many doctors say FDA‑approved bioidentical hormone therapies can be safe and effective for appropriate patients when prescribed, dosed and monitored correctly. Most professional societies warn against unproven claims about compounded BHRT and recommend using FDA‑approved products whenever possible. What the evidence and major medical groups say For bothersome menopausal symptoms (hot flashes, night sweats, vaginal dryness) hormone therapy is the most effective treatment. Benefits and risks depend on the type of hormone, dose, route (oral vs transdermal vs vaginal), whether a progestogen is needed, your age, and your medical history. The Women’s Health Initiative (WHI) raised important safety concerns (increased risk of blood clots, stroke and, with combined therapy, a small increase in breast cancer). Later analyses clarified that risk varies: starting HT nearer to menopause and using lower doses tends to carry lower cardiovascular risk. Transdermal estradiol (patch/gel) and oral micronized progesterone appear to have lower venous thromboembolism risk than some oral estrogens or synthetic progestins. Vaginal low‑dose estrogen is effective for local urogenital symptoms with minimal systemic exposure. Major organizations (North American Menopause Society, Endocrine Society, American College of Obstetricians & Gynecologists) advise: use FDA‑approved products when possible, do individualized risk/benefit discussions, avoid marketing claims that compounded BHRT is safer or superior without evidence. Compounded BHRT: the concerns Compounded hormones are made by pharmacies to individual prescriptions and are not evaluated/approved by the FDA. Concerns include inconsistent dosing, purity, lack of clinical trials proving safety/effectiveness, and sometimes marketing that misleads patients (eg, “natural” = safer). That doesn’t mean compounding is never appropriate, but it should be used only when an FDA‑approved option truly won’t meet the patient’s needs and under careful supervision. Practical guidance — what to ask your doctor Do I actually need hormone therapy for my symptoms? What are the expected benefits? Which formulation (oral, patch, gel, vaginal) and which hormone do you recommend, and why? Can we use an FDA‑approved product? What are my individualized risks (clotting, heart disease, stroke, breast cancer)? How will we monitor? If you propose compounded BHRT, why is it necessary and what evidence supports it for my situation? Examples of FDA‑approved products (commonly used, bioidentical hormones) Estradiol patches/gels: Climara, Vivelle‑Dot, Alora (transdermal estradiol) — useful when avoiding first‑pass liver effects and may carry lower clot risk. Oral estradiol: Estrace (oral estradiol) — an FDA‑approved form of bioidentical estradiol. Micronized progesterone: Prometrium — FDA‑approved bioidentical progesterone used when a progestogen is required for women with a uterus. Vaginal/local products for urogenital symptoms: Vagifem (vaginal estradiol tablet), Estring (vaginal ring), Estrace cream — low systemic absorption for local symptoms. Trusted sources and services North American Menopause Society (NAMS) — evidence‑based guidelines and a clinician directory. Endocrine Society and American College of Obstetricians & Gynecologists (ACOG) — clinical practice guidelines. Reputable academic clinics (Mayo Clinic, Cleveland Clinic, major university women’s health/menopause clinics) for second opinions or complex cases. When BHRT might be appropriate Short‑term treatment for moderate–severe menopausal vasomotor symptoms in healthy women, especially those who are younger (<60) or within about 10 years of menopause, is a common and accepted indication when individualized. Vaginal estrogens are appropriate for bothersome local symptoms at any age in many cases. Testosterone for low libido in women is sometimes considered off‑label in specialized care, but it isn’t broadly FDA‑approved for women. When to be cautious Personal or strong family history of breast cancer, active liver disease, unexplained vaginal bleeding, or a history of venous thromboembolism typically prompt avoidance or extra caution and specialist consultation. Bottom line BHRT can be safe and effective when it’s an FDA‑approved product prescribed after a careful, individualized discussion of risks and benefits and with appropriate follow‑up. Be skeptical of broad “natural” safety claims for compounded BHRT; if your clinician recommends compounded products, ask why an FDA‑approved option won’t work and what monitoring will be done. If you’d like, tell me a bit about your age, symptoms and medical history and I can outline options you can discuss with your clinician.

Mentioned in position 9 of 10